ALS, also called Charcot disease or Lou Gehrig disease, is a progressive, neurodegenerative disease with no known cure. A study has linked co-administering of cannabidiol with riluzone to delayed progression of ALS. This post from The Daily Chronic reports the findings of the study! The co-administration of cannabidiol (CBD) with the prescription drug riluzole (marketed as ... Continue Reading
ALS
STUDY: Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects
ABSTRACT: There is now a large body of data that indicates that the CB2 cannabinoid receptor type 2 (CB2) is linked to a variety of immune functional events. This functional relevance appears to be most salient in the course of inflammation, a process during which there is an increased number of receptors that are available for activation. Studies aimed at elucidating signal ... Continue Reading